XAGE Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -9.03%, SMA50 -21.56%, SMA200 -60.57%). The stock’s 14-day RSI is 41.56 (neutral), while the ATR of 0.28 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -93.91% below its high and over 7.91% above its low. Average 10-day trading volume of 9.53 thousand shares is significantly above the 3-month average of 1.77 thousand, indicating heightened recent market interest.

Longevity Health Holdings Inc. has 2.48 million shares outstanding. The public float is 1.67 million shares, elevated short interest at 0.59% of float. This equals 8.83 thousand shares. The short ratio is 0.27 days. Institutional investors hold 1.18% of the float. Insiders own 36.1%. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Longevity Health Holdings Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.01. This means the shares are trading above this model’s fair value.

The stock is currently trading near its 52-week low $0.19 and $2.45. With a market capitalization of about $270.19 thousand, Longevity Health Holdings Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.40). Key stats such as the average daily volume over the past year has been around 1.13 thousand shares, trading with heavier-than-usual volume. Headquartered in Pittsburgh, PA, Longevity Health Holdings Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Janakiram Ajjarapu, the company employs approximately 10 people and listed since September 23, 2021. Longevity Health Holdings Inc. specializes in creating plasma-based bioactive materials (PBMs) aimed at fostering tissue regeneration and repair in response to injury, illness, and the natural aging process.

Longevity Health Holdings Inc. trades at a P/E ratio of -0.05, slightly below the S&P 500 average, with a price-to-sales ratio of 0.16 and a price-to-book ratio of -0.05 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.11, also above market averages.

currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Longevity Health Holdings Inc. trading at a premium to the broader market with a P/E of -0.05. Our AI forecast model points to short-term weakness (-4.71% over two weeks), a medium-term fall (-84.12% over three months), and a longer-term gain (11.17% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Longevity Health Holdings Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -4.71%, with price expected at $0.18 by September 23, 2026, within a range of $0.14 to $0.21 3-Month Outlook: Projected fall of -84.12%, reaching $0.03 by December 08, 2026, with a range of $0.00 to $0.17. 1-Year Outlook: Projected gain of 11.17%, with price at $0.21 by September 09, 2027, within a range of $0.11 to $0.30.